The Ophthalmology Channel

Jay Duker: The Evolution of AMD Therapies

Latest in AMD Treatment

Jay S. Duker, MD, Director of the New England Eye Center, discusses the characteristics and complications of age-related macular degeneration as well as the evolution of treatments for AMD, including the development of anti-VEGF therapies in the last 6 years.

Disclosures:

Consulting Fees: Novartis, QLT, EMD Serono, ThromboGenics, Optos

Contracted Research: Carl Zeiss Meditec, Optovue

Ownership Interest: EyeNetra, Hemera, Ophthotech, Paloma

More in Ophthalmology

► 1:15

Optogenetic Therapy Restores Some Visual Function in a Man With Retinitis Pigmentosa

Ophthalmology

Based on findings from a recent study in Nature Medicine, a 58-year-old man with retinitis pigmentosa, which causes death of light-gathering cells in the retina, is able to see and...

► 0:42

Searching for Causes of Zonule Ligament Weakness

Ophthalmology

[case_player][/case_player] Researchers from the National Eye Institute (NEI), with support from the National Institutes of Health (NIH), are analyzing fibrillin-1 mutations to determine the causes of zonule fiber detachment in...

► 1:00

Prescribing Medical Marijuana?

Business of Medicine

Can doctors prescribe marijuana in states that have legalized the medical use of cannabis? The answer is no. Marijuana is classified by the federal government as a Schedule 1 drug,...

► 1:38

Can an iPad Game Help Treat Lazy Eye in Children?

Family Medicine

Lazy eye or amblyopia is one of the most common causes of visual impairment in children. A new study looked at whether a special type of iPad game could be...